Body CompositionNCT06398782
Prognostic Effect of Body Composition in Cancer Survivors
An observational study of Body Composition and Morality, run by West China Hospital.
Trial summary
This study aims to evaluate the association between body composition and mortality risk among the US population based on data from the National Health and Nutrition Examination Survey (NHANES), a nationally representative cohort. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Body Composition, Morality, Cancer Survivor
- What is being tested?
- body composition assessment
- Type of treatment
- Medical device
- How many people
- 1,500 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 1999to 31 Dec 2018
- How long will I take part?
- 230 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The data were extracted from National Health and Nutrition Examination Survey (NHANES) 1999 to 2006 and 2011 to 2018.
Who may be able to join
- Participants with cancer diagnosis beyond 18 years old.
Who cannot join
- Participants with missing cancer investigations and incomplete DXA body composition data were excluded from the study.
About this study
Official title: The Impact of DXA-Based Body Composition Phenotypes on the All-cause Mortality Among the US Cancer Survivors
This study aims to evaluate the association between body composition and mortality risk among the US population based on data from the National Health and Nutrition Examination Survey (NHANES), a nationally representative cohort.
- Conditions
- Body Composition, Morality, Cancer Survivor
- Being tested
- body composition assessment
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
body composition assessmentDevice
body composition of cancer survivors were assessed by Dual-energy X-ray absorptiometry
What is being measured
The primary outcome is the main question the study is designed to answer.
Rate of all-cause mortality
To evaluate the association between fat mass index (FMI, fat mass and height will be combined to report FMI in kg/m^2) and all-cause mortality among cancer survivors.
Measured: Jan 1 1999 to Dec 31 2019
Rate of all-cause mortality
To evaluate the association between muscle mass index (MMI, muscle mass and height will be combined to report MMI in kg/m^2) and all-cause mortality among cancer survivors.
Measured: Jan 1 1999 to Dec 31 2019
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 May 2024
- Study start1 Jan 1999
- Primary completion31 Dec 2018
- Study completion31 Dec 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Body CompositionStudies of the same condition, open and under way.
- More trials run by West China HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,500 participants (actual)
- Target duration
- 230 Months
Sponsor and investigators
- Lead sponsor
- West China Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Lei Liu, West China Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06398782
- Sponsor's protocol ID
- #98-12, #2005-06, #2011-17
- Status last verified
- Apr 2024
- First submitted
- 24 Apr 2024
- Last updated
- 3 May 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 May 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Impact of DXA-Based Body Composition Phenotypes on the All-cause Mortality Among the US Cancer Survivors
- ClinicalTrials.gov ID
- NCT06398782
- Acronym / sponsor ID
- #98-12, #2005-06, #2011-17
- Conditions
- Body Composition, Morality, Cancer Survivor
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,500 participants (actual)
- Lead sponsor
- West China HospitalUniversity, hospital or other
- Study start
- 1 Jan 1999 (actual)
- Primary completion
- 31 Dec 2018 (actual)
- Study completion
- 31 Dec 2018 (actual)
- First posted
- 3 May 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the association between body composition and mortality risk among the US population based on data from the National Health and Nutrition Examination Survey (NHANES), a nationally representative cohort.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 230 Months
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The data were extracted from National Health and Nutrition Examination Survey (NHANES) 1999 to 2006 and 2011 to 2018.
Key inclusion criteria (1 listed)
- Participants with cancer diagnosis beyond 18 years old.
Key exclusion criteria (1 listed)
- Participants with missing cancer investigations and incomplete DXA body composition data were excluded from the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| body composition assessmentbody composition of cancer survivors were assessed by Dual-energy X-ray absorptiometry | Device | – |
Primary outcome
Rate of all-cause mortality
Time frame: Jan 1 1999 to Dec 31 2019
To evaluate the association between fat mass index (FMI, fat mass and height will be combined to report FMI in kg/m^2) and all-cause mortality among cancer survivors.
Rate of all-cause mortality
Time frame: Jan 1 1999 to Dec 31 2019
To evaluate the association between muscle mass index (MMI, muscle mass and height will be combined to report MMI in kg/m^2) and all-cause mortality among cancer survivors.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 May 2024.
Related trials for Body Composition
Not yet recruitingObservational study
Evaluating Metabolic Health in Individuals With Extreme Obesity
BMI>40
Active, not recruitingObservational study
Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70)
Geriatric Assessment, Advanced Cancer
Recruiting
Dietary Intervention Study on Liver Health in Young Adults
Liver Health
RecruitingObservational study
Growing Little PEAPODS Study
Premature Birth, Premature Infant
RecruitingObservational study
Multimodal Assessment of Sarcopenia Using Shear Wave Elastography, Dual-Energy X-ray Absorptiometry, Bioelectrical Impedance Analysis, and Physical Performance Measures
Sacropenia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Body Composition and Morality, run by West China Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 May 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rate of all-cause mortality (time frame: Jan 1 1999 to Dec 31 2019). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 May 2024.